BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Unluturk U, Aksoy S, Yonem O, Bayraktar Y, Tekuzman G. Cytomegalovirus gastritis after rituximab treatment in a non-Hodgkın’s lymphoma patient. World J Gastroenterol 2006; 12(12): 1978-1979 [PMID: 16610013 DOI: 10.3748/wjg.v12.i12.1978]
URL: https://www.wjgnet.com/1007-9327/full/v12/i12/1978.htm
Number Citing Articles
1
Matthew Rong Jie Tay, Soon Thye Lim, Miriam Tao, Richard Hong-Hui Quek, Kevin Tay, Thuan Tong Tan. Cytomegalovirus infection and end-organ disease in Asian patients with lymphoma receiving chemotherapyLeukemia & Lymphoma 2014; 55(1): 182 doi: 10.3109/10428194.2013.798867
2
Qingling Hua, Yanzhe Zhu, Hu Liu. Severe and fatal adverse events risk associated with rituximab addition to B-cell non-Hodgkin’s lymphoma (B-NHL) chemotherapy: a meta-analysisJournal of Chemotherapy 2015; 27(6): 365 doi: 10.1179/1973947815Y.0000000025
3
Hung Chang, Huei-Chung Yeh, Yung-Cheng Su, Ming-Hsun Lee. Pneumocystis jiroveci Pneumonia in Patients with Non-Hodgkin's Lymphoma Receiving Chemotherapy Containing RituximabJournal of the Chinese Medical Association 2008; 71(11): 579 doi: 10.1016/S1726-4901(08)70173-4
4
Sercan Aksoy, Ömer Dizdar, Mutlu Hayran, Hakan Harputluoğlu. Infectious complications of rituximab in patients with lymphoma during maintenance therapy: a systematic review and meta-analysisLeukemia & Lymphoma 2009; 50(3): 357 doi: 10.1080/10428190902730219
5
Meyler's Side Effects of Analgesics and Anti-inflammatory Drugs2010; : 371 doi: 10.1016/B978-0-444-53273-2.50007-9
6
F.A. Goumas, F. Braun, D.C. Broering, M. Behrend. Side Effects of Drugs Annual 2009; 31: 589 doi: 10.1016/S0378-6080(09)03137-7
7
Jason Seewoodhary. Cytomegalovirus enterocolitis in a patient with diffuse large B-cell lymphoma after chemotherapy with rituximabWorld Journal of Gastroenterology 2006; 12(45): 7391-7391 doi: 10.3748/wjg.v12.i45.7391
8
Sercan Aksoy, Hakan Harputluoglu, Saadettin Kilickap, Didem Sener Dede, Omer Dizdar, Kadri Altundag, Ibrahim Barista. Rituximab-related viral infections in lymphoma patientsLeukemia & Lymphoma 2007; 48(7): 1307 doi: 10.1080/10428190701411441
9
Theodoros Kelesidis, George Daikos, Dimitrios Boumpas, Sotirios Tsiodras. Does rituximab increase the incidence of infectious complications? A narrative reviewInternational Journal of Infectious Diseases 2011; 15(1): e2 doi: 10.1016/j.ijid.2010.03.025
10
Mitsufumi Nishio, Katsuya Fujimoto, Satoshi Yamamoto, Tomoyuki Endo, Toshiya Sakai, Masato Obara, Kohki Kumano, Keisuke Yamaguchi, Yukari Takeda, Hideki Goto, Norihiro Sato, Kazuki Koizumi, Masaya Mukai, Takao Koike. Delayed redistribution of CD27, CD40 and CD80 positive B cells and the impaired in vitro immunoglobulin production in patients with non‐Hodgkin lymphoma after rituximab treatment as an adjuvant to autologous stem cell transplantationBritish Journal of Haematology 2007; 137(4): 349 doi: 10.1111/j.1365-2141.2007.06584.x
11
P. Befort, S. Riviere, A. Maran, J. Ramos, A. Lequellec. Perforations digestives itératives secondaires à une cryoglobulinémie essentielle et au cytomégalovirus : à propos d’un casLa Revue de Médecine Interne 2010; 31(2): 167 doi: 10.1016/j.revmed.2009.03.014
12
Yuko Kanbayashi, Kenichi Nomura, Yoshiko Fujimoto, Mihoko Yamashita, Muneo Ohshiro, Kousuke Okamoto, Yosuke Matsumoto, Shigeo Horiike, Tatsuya Takagi, Yoji Ishida, Masafumi Taniwaki. Risk factors for infection in haematology patients treated with rituximabEuropean Journal of Haematology 2009; 82(1): 26 doi: 10.1111/j.1600-0609.2008.01165.x
13
Meyler's Side Effects of Drugs2016; : 214 doi: 10.1016/B978-0-444-53717-1.01413-X